NVO

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease.

Novo Nordisk A/S (NVO) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $35.12 and $64.16, and it pays a dividend twice a year.

• Healthcare
• Drug Manufacturers - General
• Bagsvaerd, Denmark
• 66.7K employees
• Led by Karsten Munk Knudsen